Natriuretic peptides for early prediction of acute kidney injury in community-acquired pneumonia

Clinica Chimica Acta

Volumn 419, Issue , 2013, Pages 67-72

  Nowak, Albina ^a,b   Breidthardt, Tobias ^b   Dejung, Sarah ^a   Christ Crain, Mirjam ^b   Bingisser, Roland ^b   Drexler, Beatrice ^b   Meune, Christophe ^b   Marono, David ^b   Mosimann, Tamina ^b   Müller, Beat ^c   Müller, Christian ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Medical University Clinic   (Switzerland)

Author keywords

Acute renal failure; Community acquired pneumonia; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; CREATININE; MID REGIONAL PRO ATRIAL NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; CREATININE; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDES; PNEUMONIA; PROGNOSIS;

EID: 84874742453     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.01.014     Document Type: Article

References (38)

1. Fry A.M., Shay D.K., Holman R.C., Curns A.T., Anderson L.J. Trends in hospitalizations for pneumonia among persons aged 65years or older in the United States, 1988-2002. JAMA 2005, 294:2712-2719.
2. Murugan R., Karajala-Subramanyam V., Lee M., et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 2010, 77:527-535.
3. Akram A.R., Singanayagam A., Choudhury G., Mandal P., Chalmers J.D., Hill A.T. Incidence and prognostic implications of acute kidney injury on admission in patients with community-acquired pneumonia. Chest 2010, 138:825-832.
4. Bagshaw S.M., George C., Bellomo R. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008, 12:R47.
5. Daniels L.B., Maisel A.S. Natriuretic peptides. J Am Coll Cardiol 2007, 50:2357-2368.
6. Mueller C., Breidthardt T., Laule-Kilian K., Christ M., Perruchoud A.P. The integration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007, 137:4-12.
7. Weinfeld M.S., Chertow G.M., Stevenson L.W. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999, 138:285-290.
8. Mueller C., Laule-Kilian K., Frana B., et al. The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea. J Intern Med 2005, 258:77-85.
9. Christ-Crain M., Stolz D., Bingisser R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006, 174:84-93.
10. Potocki M., Breidthardt T., Reichlin T., et al. Midregional pro-adrenomedullin in addition to B-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study. Crit Care 2009, 13:R122.
11. Niederman M.S., Mandell L.A., Anzueto A., et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001, 163:1730-1754.
12. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
13. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
14. Lim W.S., van der Eerden M.M., Laing R., et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
15. Nowak A., Breidthardt T., Christ-Crain M., et al. Direct comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia. Chest 2012, 141:974-982.
16. Mueller C., Laule-Kilian K., Scholer A., Perruchoud A.P. B-type natriuretic peptide for risk stratification in community-acquired pneumonia. J Intern Med 2005, 258:391-393.
17. Christ-Crain M., Breidthardt T., Stolz D., et al. Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia. J Intern Med 2008, 264:166-176.
18. Maisel A., Mueller C., Nowak R., et al. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. J Am Coll Cardiol 2010, 55:2062-2076.
19. Porapakkham P., Zimmet H., Billah B., Krum H. B-type natriuretic peptide-guided heart failure therapy: a meta-analysis. Arch Intern Med 2010, 170:507-514.
20. Breidthardt T., Laule K., Strohmeyer A.H., et al. Medical and economic long-term effects of B-type natriuretic peptide testing in patients with acute dyspnea. Clin Chem 2007, 53:1415-1422.
21. Pfister R., Schneider C.A. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. Eur Heart J 2009, 30:382-383. [author reply 383].
22. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005, 9(Suppl. 4):S13-S19.
23. Jianhui L., Rosenblatt-Velin N., Loukili N., et al. Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism. Am J Physiol Heart Circ Physiol 2010, 299:H492-H501.
24. Finkel M.S., Oddis C.V., Jacob T.D., Watkins S.C., Hattler B.G., Simmons R.L. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992, 257:387-389.
25. Walley K.R., Hebert P.C., Wakai Y., Wilcox P.G., Road J.D., Cooper D.J. Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs. J Appl Physiol 1994, 76:1060-1067.
26. Ronco C., Chionh C.Y., Haapio M., Anavekar N.S., House A., Bellomo R. The cardiorenal syndrome. Blood Purif 2009, 27:114-126.
27. Breidthardt T., Christ-Crain M., Stolz D., et al. A combined cardiorenal assessment for the prediction of acute kidney injury in lower respiratory tract infections. Am J Med 2012, 125:168-175.
28. Shor R., Rozenman Y., Bolshinsky A., et al. BNP in septic patients without systolic myocardial dysfunction. Eur J Intern Med 2006, 17:536-540.
29. Ma K.K., Ogawa T., de Bold A.J. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004, 36:505-513.
30. Tomaru Ki K., Arai M., Yokoyama T., et al. Transcriptional activation of the BNP gene by lipopolysaccharide is mediated through GATA elements in neonatal rat cardiac myocytes. J Mol Cell Cardiol 2002, 34:649-659.
31. McCullough P.A., Duc P., Omland T., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003, 41:571-579.
32. Breidthardt T., Socrates T., Noveanu M., et al. Effect and clinical prediction of worsening renal function in acute decompensated heart failure. Am J Cardiol 2011, 107:730-735.
33. Franz M., Woloszczuk W., Horl W.H. Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases. Kidney Int 2001, 59:1928-1934.
34. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358:125-139.
35. Nigwekar S.U., Navaneethan S.D., Parikh C.R., Hix J.K. Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev 2009, CD006028.
36. Mehta R.L., McDonald B., Gabbai F., et al. Nephrology consultation in acute renal failure: does timing matter?. Am J Med 2002, 113:456-461.
37. Shapiro N.I., Trzeciak S., Hollander J.E., et al. The diagnostic accuracy of plasma neutrophil gelatinase-associated lipocalin in the prediction of acute kidney injury in emergency department patients with suspected sepsis. Ann Emerg Med 2010, 56:52-59. e51.
38. Pereira M., Azevedo A., Severo M., Barros H. Long-term stability of endogenous B-type natriuretic peptide after storage at -20 degrees C or -80 degrees C. Clin Chem Lab Med 2008, 46:1171-1174.